Elucidating the spatially varying relation between cervical cancer and socio-economic conditions in England

International Journal of Health Geographics

Volumn 10, Issue , 2011, Pages

  Cheng, Edith M Y ^a,b   Atkinson, Peter M ^a   Shahani, Arjan K ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Cervical cancer; Disease mapping; Geographically weighted regression; Screening

Indexed keywords

AUTOCORRELATION; CANCER; COVARIANCE ANALYSIS; DISEASE INCIDENCE; HEALTH STATUS; MAPPING; MODELING; OPTIMIZATION; REGRESSION ANALYSIS; SOCIOECONOMIC CONDITIONS; SPATIAL VARIATION;

ENGLAND; UNITED KINGDOM;

ARTICLE; CLUSTER ANALYSIS; FEMALE; GEOGRAPHIC INFORMATION SYSTEM; HUMAN; INCIDENCE; POISSON DISTRIBUTION; POVERTY; REGRESSION ANALYSIS; SOCIAL CLASS; UNITED KINGDOM; UTERINE CERVIX TUMOR;

CLUSTER ANALYSIS; ENGLAND; FEMALE; GEOGRAPHIC INFORMATION SYSTEMS; HUMANS; INCIDENCE; POISSON DISTRIBUTION; POVERTY AREAS; REGRESSION ANALYSIS; SOCIAL CLASS; UTERINE CERVICAL NEOPLASMS;

EID: 80053375170     PISSN: None     EISSN: 1476072X     Source Type: Journal    
DOI: 10.1186/1476-072X-10-51     Document Type: Article

References (51)

1. Chandler R. On the use of generalized linear models for interpreting climate variability. Environmetrics 2005, 16:699-715.
2. Green P, Richardson S. Hidden Markov models and disease mapping. Journal of the American statistical association 2002, 460:1-16.
3. Jackson C, Best N, Richardson S. Improving ecological inference using individual-level data. Statistics in medicine 2006, 25:2136-2159. 10.1002/sim.2370, 16217847.
4. Fotheringham A, Brunsdon C, Charlton M. Geographically weighted regression: the analysis of the spatially varying relationships. 2002, Chichester; John Wiley & Sons.
5. Nakaya T. Local spatial interaction modelling based on the geographically weighted regression approach. Geo Journal 2001, 53:347-358.
6. Nakaya T, Fotheringham A, Brunsdon C, Charlton M. Geographically weighted Poisson regression for disease association mapping. Statistics In Medicine 2005, 24:2695-2717. 10.1002/sim.2129, 16118814.
7. Best N, Ickstant K, Wolpert R. Spatial Poisson regression for health and exposure data measured at disparate resolutions. Journal of the American statistical association 2000, 95:1076-1088.
8. Lawson A, Clark A. Spatial mixture relative risk models applied to disease mapping. Statistics in medicine 2002, 21:359-370. 10.1002/sim.1022, 11813223.
9. Richardson S, Thomson A, Best N, Elliott P. Interpreting posterior relative risk estimates in disease-mapping studies. Environmental health perspective 2004, 112:1016-1025.
10. Fotheringham A, Brundson C, Charlton M. Geographically weighted regression: a natural evolution of the expansion method for spatial data analysis. Environment and planning A 1998, 30:1905-1927.
11. Abellan J, Fecht D, Best N, Richardson S, Briggs D. Bayesian analysis of the multivariate geographical distribution of the socio-economic environment in England. Environmetrics 2007, 18:745-758.
12. Carstairs V. Socio-economic factors at areal level and their relationship with health. Spatial Epidemiology: methods and applications 2000, 51-67. Oxford: Oxford University Press, Elliott P, Wakefield JC, Best NG, Briggs DJ.
13. Jarup L, Best N, Toledano M, Wakefield J, Elliott P. Geographical epidemiology of prostate cancer in Great Britain. International journal of cancer 2002, 97:695-699.
14. Smith J. The relationship between maternal work and other socioeconomic factors and child health in Bangladesh. Public health 1999, 113:299-302. 10.1016/S0033-3506(99)00184-5, 10637523.
15. Wakefield JC, Best NG, Richardson S, Bernardinelli L, Staines A. Statistical issues in the analysis of disease mapping data. Statistics in Medicine 2000, 19:2493-2519. 10.1002/1097-0258(20000915/30)19:17/18<2493::AID-SIM584>3.0.CO;2-D, 10960868.
16. Goddard M, Smith P. Equity of access to health care services: Theory and evidence from the UK. Social Science and Medicine 2001, 53:1149-1162. 10.1016/S0277-9536(00)00415-9, 11556606.
17. Townsend P, Davidson N, Black D, Morris JN, Smith C. Inequalities in health: the black report. 1982, Penguins: Pelican, 1.
18. Townsend P, Phillimore P, Beattie A. Health and Deprivation: inequalities and the North. 1988, London: Croom helm.
19. Judge A, Welton N, Sandhu J, Ben-Shlomo Y. Equity in access to total joint replacement of the hip and knee in England: cross sectional study. British Medical Journal 2010, 341:c4092. 10.1136/bmj.c4092, 2920379, 20702550.
20. Raine R, Mclvor M. 9 years on: what progress has been made on achieving UK health-care equity?. Lance 2006, 368:1542-1545.
21. Whynes DK, Philips Z, Avis M. Why do women participate in the English cervical cancer screening programme. Journal of Health Economics 2007, 26:306-325. 10.1016/j.jhealeco.2006.08.007, 17010459.
22. World Health Organization, Cervical cancer. , http://www.who.int/reproductivehealth/topics/cancers/en/
23. NHS Cervical Screening Programme: A pocket Guide. Sheffield 2004,
24. World Health Organization, Cancer. , http://www.who.int/mediacentre/factsheets/fs297/en/
25. Office for National Statistics, Incidence of Health of the Nation cancers by social class. , http://info.cancerresearchuk.org/cancerstats/types/cervix/riskfactors/cervical-cancer-risk-factors
26. England cervical cancer incidence rate. , http://info.cancerresearchuk.org/cancerstats/types/cervix/incidence/
27. Sing A, Monaghan J. Lower genital tract precancer: colpocopy, pathology and treatment. 2000, Oxford: Wiley-Blackwell, Second.
28. Arias-Pulido H, Joste NE, Vargas H, Wheeler CM. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. Journal of clinical microbiology 2006, 44:1755-1762. 10.1128/JCM.44.5.1755-1762.2006, 1479176, 16672403.
29. Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV 16/18 vaccine. International Journal of cancer 2003, 106:896-904.
30. Jenkins D, Sherlaw-Johnson C, Gallivan S. Can papilloma virus testing be used to improve cervical canceer screening?. International Journal of cancer 1996, 65:768-773.
31. England cervical cancer survival rate. , http://info.cancerresearchuk.org/cancerstats/types/cervix/survival/?a=5441
32. NHS Cervical Cancer Screening Programmes: Annual Review Report. Sheffield 2008,
33. NHS Cervical Screening Programme: A pocket Guide. Sheffield 2009,
34. NHS Cervical Cancer Screening Programmes: Celebrating 20 years of Screening. Sheffield 2008,
35. Gelman A, Carlin J, Stem H, Rubin D. Bayesian data analysis. 2003, Chapman and Hall, CRC.
36. Lawson A, Browne W, Rodeiro C. Disease mapping with WinBUGS and MLwiN. 2003, Chichester; Wiley.
37. Waller LA, Gotway CA. Applied Spatial Statistics for Public Health Data. 2004, John Wiley & Sons, Inc.
38. Loader C. Local regression and likelihood. 1999, New York; Springer.
39. Akaike H. A new look at the statistical model identification. Anal Biochem 1987, 162:156-159.
40. Akaike information criterion statistics: KTK Scientific Publishers. Tokyo. 1986,
41. Sugiura N. Further analysis of the data by Akaike's information criterion and the finite corrections. Communications in Statistics, theory and methods 1978, A7:13-26.
42. Hurvich C, Tsai C. Regression and time series model selection in small samples. Biometrika 1989, 76:297-307.
43. Lunn D, Whittaker J, Best N. A Bayesian toolkit for genetic association studies. Genetic Epidemiology 2006, 30:231-247. 10.1002/gepi.20140, 16544290.
44. The English Indices of Deprivation: Technical report, Office of the Deputy Prime Minister (ODPM). 2004, Neighbourhood Renewal Unit, London.
45. Wright G, Noble M. The South African Index of Multiple Deprivation 2007 at Municipality level. 2009, Department: Social Development Republic of South Africa.
46. Lavori P, Dawson R, Shera D. A multiple imputations strategy for clinical-trials with truncation of patient data. Statistics in medicine 1995, 14:1913-1925. 10.1002/sim.4780141707, 8532984.
47. Jackson C, Best N, Richardson S. Hierarchical related regression for combining aggregate and individual data in studies of socio-economic disease risk factors. Journal of the royal statistical society series A 2008, 171:159-178.
48. Herbert A, Smith J. Cervical screening - Women under 25 should be offered screening. British medical journal 2007, 334:273-273. 1796696, 17289693.
49. Raffle AE. Cervical screening: recent changes in policy regarding age and frequency are a poor use of resources. British Medical Journal 2004, 328:1272-1273. 10.1136/bmj.328.7451.1272, 420156, 15166042.
50. Ferko N, Debicki D, Barnfi F, Marocco A, Mantovani K. Estimating the long-term health and economic impact of a prophylactic cervical cancer vaccine on the burden of cervical disease in Italy. Value in health 2007, 10:A440-A441.
51. Hammerschmidt T, Siebery U, Schwarz T, Schneider A, Rogoza R, Ferko N, Welte R. A cost-effectiveness analysis of a prophylactic cervical cancer vaccine in Germany: results from a health economic model. Value in health 2007, 10:A441.